US 12257311
Multimeric T-cell modulatory polypeptides and methods of use thereof
granted A61KA61K2039/605A61K2039/6056
Quick answer
US patent 12257311 (Multimeric T-cell modulatory polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/605, A61K2039/6056, A61K39/001114, A61K39/001153